Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:109 (20 January), doi:10.1136/bmj.39094.396123.1F
Gravelle et al report the impact of case management (Evercare) on frail elderly patients.1 The Evercare pilot study was based on the findings of one quasi-experimental study of case management in US nursing homes, albeit one with impressive results. It was imported to the United Kingdom in 10 pilot sites and applied to a very different group of patients (community dwelling), in a very different health economy, with different nursing skills and information system. Even the author of the original paper expressed surprise that the intervention had been implemented in this way.2 This cost the UK taxpayer over £4m (
6m; $7.8m)not to mention the cost of "backfill" for community nursing posts vacated by the new advanced practitioner nurses. If the Department of Health had any regard for evidence it would not have ignored two excellent systematic reviews3 4 that showed no consistent evidence for the effectiveness of case management in preventing hospital attendances or admissions, reducing health costs, or improving function. Nor would they have repeatedly touted the "Castlefields" model5 (never published in a peer reviewed journal) as good evidence for chronic disease management. Most importantly, they would have commissioned a good randomised controlled trial of the intervention in the UK instead of commissioning an evaluation almost as an afterthought.
The only parties to emerge with credit from this exercise are the research team who did their best to perform a quasi experimental evaluation given the constraints of the project handed to them.
David Oliver, senior lecturer
1 Institute of Health Sciences, University of Reading, Reading RG1 5AQ d.oliver@reading.ac.uk